Cargando…

Long-Term Follow-Up of Patients with Chronic Chagas Disease and Implantable Cardioverter-Defibrillator

BACKGROUND/OBJECTIVES: Chronic Chagas heart disease (ChHD) is associated with ventricular tachyarrhythmias and an increased risk of sudden cardiac death. Little is known about the effectiveness of implantable cardioverter-defibrillator (ICD) therapy in this population. The objective of this study wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pereira, Francisca Tatiana Moreira, Rocha, Eduardo Arrais, Monteiro, Marcelo de Paula Martins, Neto, Almino Cavalcante Rocha, Daher, Elisabeth de Francesco, Sobrinho, Carlos Roberto Martins Rodrigues, Neto, Roberto da Justa Pires
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Devices
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285790/ https://www.ncbi.nlm.nih.gov/pubmed/24467488 http://dx.doi.org/10.1111/pace.12342

Ejemplares similares

Clinical Course After Cardioverter-Defibrillator Implantation: Chagasic Versus Ischemic Patients
por: Pereira, Francisca Tatiana Moreira, et al.
Publicado: (2016)

Diagnosis and management of subcutaneous implantable cardioverter‐defibrillator infections based on process mapping
por: Baddour, Larry M., et al.
Publicado: (2020)

Remote monitoring of implantable cardioverter defibrillators: Patient experiences and preferences for follow‐up
por: Timmermans, Ivy, et al.
Publicado: (2019)

Impact of the COVID‐19 lockdown on the arrhythmic burden of patients with implantable cardioverter‐defibrillators
por: Sassone, Biagio, et al.
Publicado: (2021)

Healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the WEBCARE study)
por: Broers, Eva R., et al.
Publicado: (2019)

Long‐term follow‐up of implantable cardioverter defibrillator patients with regard to appropriate therapy, complications, and mortality
por: Mattsson, Gustav, et al.
Publicado: (2020)

Development and Validation of Predictive Models of Cardiac Mortality and Transplantation in Resynchronization Therapy
por: Rocha, Eduardo Arrais, et al.
Publicado: (2015)

Echocardiographic Predictors of Worse Outcome After Cardiac Resynchronization Therapy
por: Rocha, Eduardo Arrais, et al.
Publicado: (2015)

Association between implantable cardioverter-defibrillator and survival in patients awaiting heart transplantation: A meta-analysis and systematic review
por: Lin, Andrew Y., et al.
Publicado: (2021)

Implantable cardioverter-defibrillator–related procedures and associated complications in continuous flow left ventricular assist device recipients: A multicenter experience
por: Ravichandran, Ashwin, et al.
Publicado: (2021)

Renal function and the long‐term clinical outcomes of cardiac resynchronization therapy with or without defibrillation
por: Leyva, Francisco, et al.
Publicado: (2019)

Predictors of primary prevention implantable cardioverter‐defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all‐cause mortality
por: Schrage, Benedikt, et al.
Publicado: (2022)

Subcutaneous implantable cardioverter-defibrillator generator removal: a multicenter analysis
por: Luker, J, et al.
Publicado: (2023)

Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience
por: Kutyifa, Valentina, et al.
Publicado: (2014)

Remote monitoring of pacemakers and defibrillators: Effective and safe in Brazil?
por: Rocha, Maria Eduarda Quidute Arrais, et al.
Publicado: (2022)

Appropriate therapy for implantable cardioverter defibrillators used as primary versus secondary prophylaxis
por: Thuraiaiyah, J, et al.
Publicado: (2023)

Pulsed-field ablation in patients with permanent pacemaker or implantable cardioverter defibrillator: Is it safe?
por: Lennerz, C, et al.
Publicado: (2023)

Implantable cardioverter-defibrillator prevents sudden death in patients with Chagas cardiomyopathy in the Brazilian Amazon
por: Couceiro, Katia do Nascimento, et al.
Publicado: (2021)

Syncope in Patients with Cardiac Pacemakers
por: Rocha, Eduardo Arrais, et al.
Publicado: (2021)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Pacemaker and Defibrillator Implantation and Programming in Patients with Deep Brain Stimulation
por: Elliott, Mark, et al.
Publicado: (2019)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Leadless pacemakers as a new alternative for pacemaker lead‐related superior vena cava syndrome: A case report
por: Curnis, Antonio, et al.
Publicado: (2022)

Blood stream infection in patients with implantable-cardioverter defibrillator admitted to non-cardiology units: incidence, diagnostic work-up and outcome
por: Oezkartal, T, et al.
Publicado: (2023)

Defibrillation Threshold Testing for Right-sided Device Implants: A Review to Inform Shared Decision-making, in Association with the British Heart Rhythm Society
por: Pope, Michael TB, et al.
Publicado: (2023)

Home delivery of the communicator for remote monitoring of cardiac implantable devices: A multicenter experience during the covid‐19 lockdown
por: Magnocavallo, Michele, et al.
Publicado: (2021)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Strategies to increase the INGEVITY lead strength during lead extraction procedures based on laboratory bench testing
por: Vatterott, Pierce, et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

In vivo preliminary test of a new biparietal bidirectional bipolar radiofrequency magnetic coupling system
por: Matteucci, Francesco, et al.
Publicado: (2021)

Long‐term outcomes of cardiac resynchronization therapy in adult congenital heart disease
por: Leyva, Francisco, et al.
Publicado: (2019)

Evolving use and indications for implantable cardioverter defibrillators
por: de Groot, J. R.
Publicado: (2018)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Subcutaneous Implantable Cardioverter Defibrillator: A Contemporary Overview
por: Guarracini, Fabrizio, et al.
Publicado: (2023)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

First experience with the wearable cardioverter defibrillator in the Netherlands
por: Knops, R. E., et al.
Publicado: (2011)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1b2ncr1054b326hquul43rarpk